BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34416247)

  • 1. Post-translational modifications talk and crosstalk to class IIa histone deacetylases.
    Guttzeit S; Backs J
    J Mol Cell Cardiol; 2022 Jan; 162():53-61. PubMed ID: 34416247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
    Eom GH; Kook H
    Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and post-translational regulation of cardiac class IIa histone deacetylase isoforms.
    Weeks KL; Avkiran M
    J Physiol; 2015 Apr; 593(8):1785-97. PubMed ID: 25362149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in class IIa histone deacetylases research.
    Asfaha Y; Schrenk C; Alves Avelar LA; Hamacher A; Pflieger M; Kassack MU; Kurz T
    Bioorg Med Chem; 2019 Nov; 27(22):115087. PubMed ID: 31561937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy.
    Kee HJ; Kook H
    J Biomed Biotechnol; 2011; 2011():928326. PubMed ID: 21151616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.
    Wright LH; Menick DR
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H199-206. PubMed ID: 27208161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-translational modifications regulate class IIa histone deacetylase (HDAC) function in health and disease.
    Mathias RA; Guise AJ; Cristea IM
    Mol Cell Proteomics; 2015 Mar; 14(3):456-70. PubMed ID: 25616866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart.
    Habibian J; Ferguson BS
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylases in modulating cardiac disease and their clinical translational and therapeutic implications.
    Wang Z; Zhao YT; Zhao TC
    Exp Biol Med (Maywood); 2021 Jan; 246(2):213-225. PubMed ID: 32727215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
    Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
    Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
    Bai G; Wei D; Zou S; Ren K; Dubner R
    Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
    Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
    Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation.
    Zhang D; Hu X; Henning RH; Brundel BJ
    Cardiovasc Res; 2016 Apr; 109(4):519-26. PubMed ID: 26645980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.
    Godoy LD; Lucas JE; Bender AJ; Romanick SS; Ferguson BS
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27981795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy.
    Patra S; Panigrahi DP; Praharaj PP; Bhol CS; Mahapatra KK; Mishra SR; Behera BP; Jena M; Bhutia SK
    Cell Mol Life Sci; 2019 Sep; 76(17):3263-3282. PubMed ID: 30982077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates.
    Bouyahya A; El Hachlafi N; Aanniz T; Bourais I; Mechchate H; Benali T; Shariati MA; Burkov P; Lorenzo JM; Wilairatana P; Mubarak MS; El Omari N
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of class IIa HDAC activities: it is not only matter of subcellular localization.
    Di Giorgio E; Brancolini C
    Epigenomics; 2016 Feb; 8(2):251-69. PubMed ID: 26791815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
    Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
    J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.